NEW YORK – Cancer Genetics on Friday reported a 5 percent decrease in second quarter revenues, which it said was primarily due to the timing of discovery services studies.
NEW YORK – Cancer Genetics on Friday reported a 5 percent decrease in second quarter revenues, which it said was primarily due to the timing of discovery services studies.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.